BR0314654A - Método de determinação de grupamentos especìficos que constituem as heparinas ou as heparinas de baixo peso molecular - Google Patents

Método de determinação de grupamentos especìficos que constituem as heparinas ou as heparinas de baixo peso molecular

Info

Publication number
BR0314654A
BR0314654A BR0314654-5A BR0314654A BR0314654A BR 0314654 A BR0314654 A BR 0314654A BR 0314654 A BR0314654 A BR 0314654A BR 0314654 A BR0314654 A BR 0314654A
Authority
BR
Brazil
Prior art keywords
heparins
molecular weight
low molecular
specific groups
determining specific
Prior art date
Application number
BR0314654-5A
Other languages
English (en)
Other versions
BRPI0314654B8 (pt
BRPI0314654B1 (pt
Inventor
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0211724A external-priority patent/FR2844808B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0314654A publication Critical patent/BR0314654A/pt
Publication of BRPI0314654B1 publication Critical patent/BRPI0314654B1/pt
Publication of BRPI0314654B8 publication Critical patent/BRPI0314654B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"MéTODO DE DETERMINAçãO DE GRUPAMENTOS ESPECìFICOS QUE CONSTITUEM AS HEPARINAS OU AS HEPARINAS DE BAIXO PESO MOLECULAR". A presente invenção refere-se a um método de análise das heparinas ou heparinas de baixo peso molecular, caracterizado pelo fato de a amostra a dosar ser despolimerizada por ação de heparinases, depois, se for o caso, o despolimerizado obtido ser reduzido, depois se fazer uma análise por cromatografia líquida de Desempenho.
BRPI0314654A 2002-09-23 2003-09-22 método de análise de heparinas ou de heparinas de baixo peso molecular, para buscar a presença de cadeias de oligossacarídeos cuja terminação é modificada por uma ligação 1,6-anidro, e derivados das mesmas BRPI0314654B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0211724A FR2844808B1 (fr) 2002-09-23 2002-09-23 Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
US42248202P 2002-10-31 2002-10-31
PCT/FR2003/002782 WO2004027087A2 (fr) 2002-09-23 2003-09-22 Methode de determination de groupements specifiques constituant les heparines

Publications (3)

Publication Number Publication Date
BR0314654A true BR0314654A (pt) 2005-08-02
BRPI0314654B1 BRPI0314654B1 (pt) 2016-01-05
BRPI0314654B8 BRPI0314654B8 (pt) 2021-05-25

Family

ID=32031841

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314654A BRPI0314654B8 (pt) 2002-09-23 2003-09-22 método de análise de heparinas ou de heparinas de baixo peso molecular, para buscar a presença de cadeias de oligossacarídeos cuja terminação é modificada por uma ligação 1,6-anidro, e derivados das mesmas

Country Status (18)

Country Link
EP (1) EP1558755B1 (pt)
JP (1) JP4373917B2 (pt)
KR (1) KR20050057550A (pt)
CN (1) CN101747385B (pt)
AU (1) AU2003279430B2 (pt)
BR (1) BRPI0314654B8 (pt)
CA (1) CA2499537A1 (pt)
CO (1) CO5721022A2 (pt)
HK (1) HK1081601A1 (pt)
HR (1) HRP20050273A2 (pt)
IL (1) IL167569A (pt)
MA (1) MA27393A1 (pt)
MX (1) MXPA05001945A (pt)
NO (1) NO20051744L (pt)
PL (1) PL376709A1 (pt)
RS (1) RS20050230A (pt)
RU (1) RU2359037C2 (pt)
WO (1) WO2004027087A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP1582531A1 (en) * 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
FR2880951B1 (fr) * 2005-01-19 2015-09-18 Aventis Pharma Sa Methode d'analyse d'oligosaccharides a partir de plasma sanguin
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
BRPI0621470A2 (pt) 2006-12-05 2011-12-13 Glycoscience Lab Inc agente terapêutico para artrite degenerativa
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2526122B1 (en) 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN103755823B (zh) * 2013-12-12 2016-09-28 中国海洋大学 一种硫酸软骨素中硫酸角质素的纯化与检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8102987A (en) * 1986-10-02 1988-04-21 Massachusetts Institute Of Technology Neutralizing anticoagulant activities of low molecular weight heparin
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe

Also Published As

Publication number Publication date
RU2005112240A (ru) 2005-11-20
JP4373917B2 (ja) 2009-11-25
RU2359037C2 (ru) 2009-06-20
JP2006500019A (ja) 2006-01-05
PL376709A1 (pl) 2006-01-09
MXPA05001945A (es) 2005-04-28
AU2003279430A1 (en) 2004-04-08
AU2003279430B2 (en) 2008-09-11
CN101747385A (zh) 2010-06-23
BRPI0314654B8 (pt) 2021-05-25
NO20051744L (no) 2005-04-08
CO5721022A2 (es) 2007-01-31
WO2004027087A2 (fr) 2004-04-01
EP1558755A2 (fr) 2005-08-03
EP1558755B1 (fr) 2012-10-24
MA27393A1 (fr) 2005-06-01
CN101747385B (zh) 2013-03-06
KR20050057550A (ko) 2005-06-16
IL167569A (en) 2010-12-30
BRPI0314654B1 (pt) 2016-01-05
HK1081601A1 (en) 2006-05-19
RS20050230A (en) 2007-06-04
WO2004027087A3 (fr) 2005-06-09
HRP20050273A2 (en) 2006-05-31
CA2499537A1 (fr) 2004-04-01

Similar Documents

Publication Publication Date Title
BRPI0509068A (pt) métodos para determinar quantitativamente heparinas de constituição especìfica ou heparinas de baixo peso molecular usando hplc
Militsopoulou et al. Determination of twelve heparin‐and heparan sulfate‐derived disaccharides as 2‐aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser‐induced fluorescence detection
HRP20050273A2 (en) Method of determining specific groups forming heparins
Ampofo et al. Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis
Ivanov et al. Capillary electrophoresis coupled with 1, 1′-thiocarbonyldiimidazole derivatization for the rapid detection of total homocysteine and cysteine in human plasma
BRPI0512281A (pt) análise dimensional de conjugados de sacarìdeo com gpc & sec-mals
EP2314632A3 (en) Oligosaccharidic compounds derived from heparin
SE0303249D0 (sv) Hematocrit and analyte concentration determination
TW200617386A (en) Method for analyzing oligomeric proanthocyanidin (opc)
BRPI0412412A (pt) dispositivo e processo para realização simultánea da determinação de grupos sangüìneos, contraprova de soro e teste de busca de anticorpos
BR0114343A (pt) Ensaio de microdisposição de alérgenos
Qiao et al. Recent advances in biotechnology for heparin and heparan sulfate analysis
CL2008002525A1 (es) Reactivo de inmunoensayo que comprende un agente de union a la troponina i y un sulfato de condroitina para reducir la union inespesifica en un ensayo para troponina i; composicion de muestra; metodo para detectar troponina i.
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
BR0206318A (pt) Detecção de analitos
BR112013013991A2 (pt) método para medir pelo menos, uma propriedade de uma amostra predominantemente líquida
ATE522812T1 (de) Verfahren und zusammensetzung zum bestimmen von homocystein
BRPI0412030A (pt) método de ensaio, método para identificar um sensor que especificamente se liga em um alvo centrossÈmico, e, solução alcoólica conservante
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
BR0211636A (pt) Método para análise de desempenho de sensor para um sistema de sensores, dispositivo para cálculo analìtico de um desempenho de um sistema de sensor, e, uso do método e do dispositivo
AR041320A1 (es) Metodo de determinacion de agrupamientos especificos que constituyen las heparinas o las heparinas de bajo peso molecular
Barrowcliffe et al. The anticoagulant activity of heparin: measurement and relationship to chemical structure
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
BRPI0515517A (pt) processo para a preparação de ciclopentanona, e, uso de uma mistura de hidrocarboneto contendo ciclopenteno
ATE259964T1 (de) Kompetitives assay-verfahren

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/09/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.